108 related articles for article (PubMed ID: 6576195)
1. Murine natural antitumor antibodies. III. Interferon treatment of a natural killer-resistant lymphoma: augmentation of natural antibody reactivity and susceptibility to in vivo natural resistance.
Miller VE; Pohajdak B; Greenberg AH
J Natl Cancer Inst; 1983 Aug; 71(2):377-84. PubMed ID: 6576195
[TBL] [Abstract][Full Text] [Related]
2. Tumor selection in vivo for reduced sensitivity to natural resistance and natural antibodies.
Chow DA
J Natl Cancer Inst; 1984 Feb; 72(2):339-46. PubMed ID: 6582320
[TBL] [Abstract][Full Text] [Related]
3. [In vitro cytolysis mediated by NK effectors: modification of the susceptibility of the target cell by in vivo treatment with DTIC].
Migliorati G; Romani L; Fioretti MC
Boll Soc Ital Biol Sper; 1981 May; 57(9):1024-30. PubMed ID: 7284118
[TBL] [Abstract][Full Text] [Related]
4. Suppression of NK-mediated natural resistance by interferon treatment of murine lymphomas.
Greenberg AH; Miller V; Jablonski T; Pohajdak B
J Immunol; 1984 Apr; 132(4):2129-34. PubMed ID: 6199424
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic alterations in tumors that developed from threshold subcutaneous inocula. I. Reduced binding of natural antibodies and sensitivity to hypotonic lysis.
Brown GW; Lesiuk TP; Chow DA
J Immunol; 1986 Apr; 136(8):3116-23. PubMed ID: 3958491
[TBL] [Abstract][Full Text] [Related]
6. Interferon and butyrate treatment leads to a decreased sensitivity of NK target cells to lysis by homologous but not by heterologous effector cells.
Laskay T; Kiessling R
Nat Immun Cell Growth Regul; 1986; 5(4):211-20. PubMed ID: 3095635
[TBL] [Abstract][Full Text] [Related]
7. Transplantability and sensitivity to natural killer cells of aclarubicin-resistant murine lymphoma.
Sugimoto Y; Hirakawa Y; Tanaka N; Tahara M; Sato I; Nishimura T; Suzuki H; Tanaka N
Cancer Res; 1986 Nov; 46(11):5646-8. PubMed ID: 3463416
[TBL] [Abstract][Full Text] [Related]
8. Natural resistance to tumors is a heterogeneous immunological phenomenon. Evidence for non-NK cell mechanisms.
Chow DA; Miller VE; Carlson GA; Pohajdak B; Greenberg AH
Invasion Metastasis; 1981; 1(4):205-19. PubMed ID: 6203863
[TBL] [Abstract][Full Text] [Related]
9. Acute rejection of interferon-treated leukemia cells injected into lethally irradiated syngeneic mice.
Neri M; Zei T; Tentori L; Bonmassar E; Affabris E; Iorio AM
Nat Immun; 1993; 12(6):302-15. PubMed ID: 7505668
[TBL] [Abstract][Full Text] [Related]
10. Genetics, regulation, and specificity of murine natural antitumor antibodies and natural killer cells.
Chow DA; Wolosin LB; Greenberg AH
J Natl Cancer Inst; 1981 Aug; 67(2):445-53. PubMed ID: 6943381
[TBL] [Abstract][Full Text] [Related]
11. Role of natural killer cells in the mechanism of the antitumor effect of interferon on Moloney sarcoma virus-transformed cells.
Fresa KL; Murasko DM
Cancer Res; 1986 Jan; 46(1):81-8. PubMed ID: 3940213
[TBL] [Abstract][Full Text] [Related]
12. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
Lotzová E; Savary CA; Stringfellow DA
J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603
[TBL] [Abstract][Full Text] [Related]
13. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
Gjedde SB
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of augmentation of natural killer cell activity by syngeneic tumor cells: role of macrophage-derived factor in NK boosting.
Kawase I; Urdal DL; Newman W; Henney CS
Int J Cancer; 1983 Mar; 31(3):365-72. PubMed ID: 6402456
[TBL] [Abstract][Full Text] [Related]
15. Inverse correlation between natural antitumor antibodies and tumor susceptibility in individual xid-bearing mice.
Bennet RD; Chow DA
Nat Immun Cell Growth Regul; 1991; 10(1):45-55. PubMed ID: 2057021
[TBL] [Abstract][Full Text] [Related]
16. Tumor progression in vitro: the paradoxical natural antibody and complement-selected phenotype.
Chow DA; Chan J
Nat Immun Cell Growth Regul; 1987; 6(4):189-204. PubMed ID: 3683415
[TBL] [Abstract][Full Text] [Related]
17. Comparison between murine natural antibodies and natural killer cells: recognition of separate target structures as revealed by differential in vitro expression and dependence on glycosylation.
Grönberg A; Eriksson E; Sinangil F; Rönnholm M; Feizi T; Minden P; Kiessling R
J Natl Cancer Inst; 1985 Jan; 74(1):67-75. PubMed ID: 2982055
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
[TBL] [Abstract][Full Text] [Related]
19. Effect of in vitro interferon treatment on the rapid clearance of murine leukemia cells in vivo.
Neri M; Zei T; Rossi GB; Coccia EM; Bonmassar E; Iorio AM
J Biol Regul Homeost Agents; 1990; 4(2):60-6. PubMed ID: 1701956
[TBL] [Abstract][Full Text] [Related]
20. Differential CD45 isoform expression accompanies reduced natural antibody binding in L5178Y-F9 tumor progression.
Zhang ZY; Chow DA
J Immunol; 1997 Jul; 159(1):344-50. PubMed ID: 9200472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
